IRIS Accounts Production v25.4.0.155 07849130 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 Medium entities true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078491302024-03-31078491302025-03-31078491302024-04-012025-03-31078491302023-03-31078491302023-04-012024-03-31078491302024-03-3107849130ns15:EnglandWales2024-04-012025-03-3107849130ns14:PoundSterling2024-04-012025-03-3107849130ns10:Director12024-04-012025-03-3107849130ns10:Director22024-04-012025-03-3107849130ns10:CompanySecretary12024-04-012025-03-3107849130ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107849130ns10:MediumEntities2024-04-012025-03-3107849130ns10:Audited2024-04-012025-03-3107849130ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3107849130ns10:Medium-sizedCompaniesRegimeForAccounts2024-04-012025-03-3107849130ns10:FullAccounts2024-04-012025-03-3107849130ns10:OrdinaryShareClass12024-04-012025-03-3107849130ns10:Director32024-04-012025-03-3107849130ns10:RegisteredOffice2024-04-012025-03-3107849130ns5:CurrentFinancialInstruments2025-03-3107849130ns5:CurrentFinancialInstruments2024-03-3107849130ns5:Non-currentFinancialInstruments2025-03-3107849130ns5:Non-currentFinancialInstruments2024-03-3107849130ns5:ShareCapital2025-03-3107849130ns5:ShareCapital2024-03-3107849130ns5:SharePremium2025-03-3107849130ns5:SharePremium2024-03-3107849130ns5:CapitalRedemptionReserve2025-03-3107849130ns5:CapitalRedemptionReserve2024-03-3107849130ns5:RetainedEarningsAccumulatedLosses2025-03-3107849130ns5:RetainedEarningsAccumulatedLosses2024-03-3107849130ns5:ShareCapital2023-03-3107849130ns5:RetainedEarningsAccumulatedLosses2023-03-3107849130ns5:SharePremium2023-03-3107849130ns5:CapitalRedemptionReserve2023-03-3107849130ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-3107849130ns5:CapitalRedemptionReserve2023-04-012024-03-3107849130ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-3107849130ns5:CapitalRedemptionReserve2024-04-012025-03-3107849130ns5:LandBuildingsns5:ShortLeaseholdAssets2024-04-012025-03-3107849130ns5:PlantMachinery2024-04-012025-03-3107849130ns5:FurnitureFittings2024-04-012025-03-3107849130ns5:ComputerEquipment2024-04-012025-03-3107849130ns10:HighestPaidDirector2024-04-012025-03-3107849130ns10:HighestPaidDirector2023-04-012024-03-3107849130ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-04-012025-03-3107849130ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-04-012024-03-3107849130ns5:OwnedAssets2024-04-012025-03-3107849130ns5:OwnedAssets2023-04-012024-03-3107849130ns5:LeasedAssets2024-04-012025-03-3107849130ns5:LeasedAssets2023-04-012024-03-310784913012024-04-012025-03-310784913012023-04-012024-03-3107849130ns5:HirePurchaseContracts2024-04-012025-03-3107849130ns5:HirePurchaseContracts2023-04-012024-03-3107849130ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-3107849130ns5:PlantMachinery2024-03-3107849130ns5:FurnitureFittings2024-03-3107849130ns5:ComputerEquipment2024-03-3107849130ns5:LandBuildingsns5:ShortLeaseholdAssets2025-03-3107849130ns5:PlantMachinery2025-03-3107849130ns5:FurnitureFittings2025-03-3107849130ns5:ComputerEquipment2025-03-3107849130ns5:LandBuildingsns5:ShortLeaseholdAssets2024-03-3107849130ns5:PlantMachinery2024-03-3107849130ns5:FurnitureFittings2024-03-3107849130ns5:ComputerEquipment2024-03-3107849130ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-03-3107849130ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2025-03-3107849130ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-04-012025-03-3107849130ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-03-3107849130ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107849130ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107849130ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-03-3107849130ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-03-3107849130ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2025-03-3107849130ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-03-3107849130ns5:HirePurchaseContracts2025-03-3107849130ns5:HirePurchaseContracts2024-03-3107849130ns5:WithinOneYear2025-03-3107849130ns5:WithinOneYear2024-03-3107849130ns5:BetweenOneFiveYears2025-03-3107849130ns5:BetweenOneFiveYears2024-03-3107849130ns5:AllPeriods2025-03-3107849130ns5:AllPeriods2024-03-3107849130ns5:Secured2025-03-3107849130ns5:Secured2024-03-3107849130ns5:DeferredTaxation2024-03-3107849130ns5:DeferredTaxation2024-04-012025-03-3107849130ns5:DeferredTaxation2025-03-3107849130ns10:OrdinaryShareClass12025-03-3107849130ns5:RetainedEarningsAccumulatedLosses2024-03-3107849130ns5:SharePremium2024-03-3107849130ns5:CapitalRedemptionReserve2024-03-3107849130ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2024-04-012025-03-3107849130ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2023-04-012024-03-3107849130ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2025-03-3107849130ns5:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity2024-03-3107849130ns5:OtherRelatedPartyRelationshipType2ComponentTotalRelatedParties2024-04-012025-03-3107849130ns5:OtherRelatedPartyRelationshipType2ComponentTotalRelatedParties2023-04-012024-03-3107849130ns5:OtherRelatedPartyRelationshipType2ComponentTotalRelatedParties2025-03-3107849130ns5:OtherRelatedPartyRelationshipType2ComponentTotalRelatedParties2024-03-31
REGISTERED NUMBER: 07849130 (England and Wales)











Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 31 March 2025

for

Camstar Ingredients Limited

Camstar Ingredients Limited (Registered number: 07849130)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 4

Income Statement 8

Other Comprehensive Income 9

Balance Sheet 10

Statement of Changes in Equity 11

Cash Flow Statement 12

Notes to the Cash Flow Statement 13

Notes to the Financial Statements 15


Camstar Ingredients Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: E J B Starke
Mrs T Dewsbery-Clark
M T Hoxworth





SECRETARY: Mrs T Dewsbery-Clark





REGISTERED OFFICE: Chestnuts Farm
Langton Green
Eye
Suffolk
IP23 7HL





REGISTERED NUMBER: 07849130 (England and Wales)





AUDITORS: Knights Lowe Limited
Eldo House
Kempson Way
Suffolk Business Park
Bury St Edmunds
Suffolk
IP32 7AR

Camstar Ingredients Limited (Registered number: 07849130)

Strategic Report
for the Year Ended 31 March 2025

The directors present their strategic report for the year ended 31 March 2025.

REVIEW OF BUSINESS
Profitability has been negatively impacted, largely driven by heightened market competition. We anticipate the competitive landscape to continue to be a major challenge.

Key performance indicators
The key performance indicators for Camstar Ingredients Ltd are net profit margin and gross profit margin. The company have chosen these to represent the company's performance and position as increasing turnover has been a key objective for the company in recent years. Net profit is a key indicator for the company as it gives a more holistic view of how the company is performing and allows them to review their costs for maximum efficiencies.

The results for the year, as shown on the statement of comprehensive income, shows a gross profit margin of 19.5% (2024: 24.3%) and net profit margin of -1.5% (2024: 7.1%).

Revenue has decreased from £16.5m to £15.6m in 2025.

ON BEHALF OF THE BOARD:





Mrs T Dewsbery-Clark - Secretary


4 November 2025

Camstar Ingredients Limited (Registered number: 07849130)

Report of the Directors
for the Year Ended 31 March 2025

The directors present their report with the financial statements of the company for the year ended 31 March 2025.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of production and sale of spice blends and sauces.

DIVIDENDS
No dividends will be distributed for the year ended 31 March 2025.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

E J B Starke
Mrs T Dewsbery-Clark
M T Hoxworth

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Knights Lowe Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:



Mrs T Dewsbery-Clark - Secretary


4 November 2025

Report of the Independent Auditors to the Members of
Camstar Ingredients Limited

Opinion
We have audited the financial statements of Camstar Ingredients Limited (the 'company') for the year ended 31 March 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Camstar Ingredients Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Camstar Ingredients Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

- the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
- we identified the laws and regulations applicable to the company through discussions with the director and other management, and from our commercial knowledge and experience of the companies operating sector;
- we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, taxation legislation, data protection, anti-bribery, employment, environmental and health and safety legislation;
- we assessed the extent of compliance with the laws and regulations identified above through making enquiries of management and inspecting legal correspondence; and
- identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud;
- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations;

To address the risk of fraud through management bias and override of controls, we:
- performed analytical procedures to identify any unusual or unexpected relationships;
- tested journal entries to identify unusual transactions;
- assessed whether judgements and assumptions made in determining the accounting estimates were indicative of potential bias;
- investigated the rationale behind significant or unusual transactions;

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
- agreeing financial statement disclosures to underlying supporting documentation;
- reading the minutes of meetings of those charged with governance;
- enquiring of management as to actual and potential litigation and claims;
- reviewing correspondence with HMRC, relevant regulators including the Environment Agency and the company's legal advisors;


There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Camstar Ingredients Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




James Knights BSc FCA (Senior Statutory Auditor)
for and on behalf of Knights Lowe Limited
Eldo House
Kempson Way
Suffolk Business Park
Bury St Edmunds
Suffolk
IP32 7AR

4 November 2025

Camstar Ingredients Limited (Registered number: 07849130)

Income Statement
for the Year Ended 31 March 2025

2025 2024
Notes £    £    £    £   

TURNOVER 15,593,478 16,544,220

Cost of sales 12,553,995 12,520,564
GROSS PROFIT 3,039,483 4,023,656

Distribution costs 372,349 431,664
Administrative expenses 2,765,755 2,136,567
3,138,104 2,568,231
OPERATING (LOSS)/PROFIT 4 (98,621 ) 1,455,425

Interest receivable and similar income 6,354 2,034
(92,267 ) 1,457,459

Interest payable and similar expenses 5 144,060 190,330
(LOSS)/PROFIT BEFORE TAXATION (236,327 ) 1,267,129

Tax on (loss)/profit 6 4,830 85,267
(LOSS)/PROFIT FOR THE FINANCIAL YEAR (241,157 ) 1,181,862

Camstar Ingredients Limited (Registered number: 07849130)

Other Comprehensive Income
for the Year Ended 31 March 2025

2025 2024
Notes £    £   

(LOSS)/PROFIT FOR THE YEAR (241,157 ) 1,181,862


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

(241,157

)

1,181,862

Camstar Ingredients Limited (Registered number: 07849130)

Balance Sheet
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 7 2,684,667 2,672,687

CURRENT ASSETS
Stocks 8 1,959,404 1,938,247
Debtors 9 2,630,438 2,751,368
Cash at bank - 38,874
4,589,842 4,728,489
CREDITORS
Amounts falling due within one year 10 4,131,117 3,923,032
NET CURRENT ASSETS 458,725 805,457
TOTAL ASSETS LESS CURRENT LIABILITIES 3,143,392 3,478,144

CREDITORS
Amounts falling due after more than one
year

11

(200,692

)

(318,289

)

PROVISIONS FOR LIABILITIES 15 (568,812 ) (544,810 )
NET ASSETS 2,373,888 2,615,045

CAPITAL AND RESERVES
Called up share capital 16 990 990
Share premium 17 4,165 4,165
Capital redemption reserve 17 80 80
Retained earnings 17 2,368,653 2,609,810
SHAREHOLDERS' FUNDS 2,373,888 2,615,045

The financial statements were approved by the Board of Directors and authorised for issue on 4 November 2025 and were signed on its behalf by:




E J B Starke - Director



Mrs T Dewsbery-Clark - Director


Camstar Ingredients Limited (Registered number: 07849130)

Statement of Changes in Equity
for the Year Ended 31 March 2025

Called up Capital
share Retained Share redemption Total
capital earnings premium reserve equity
£    £    £    £    £   
Balance at 1 April 2023 990 1,427,948 4,165 80 1,433,183

Changes in equity
Total comprehensive income - 1,181,862 - - 1,181,862
Balance at 31 March 2024 990 2,609,810 4,165 80 2,615,045

Changes in equity
Total comprehensive income - (241,157 ) - - (241,157 )
Balance at 31 March 2025 990 2,368,653 4,165 80 2,373,888

Camstar Ingredients Limited (Registered number: 07849130)

Cash Flow Statement
for the Year Ended 31 March 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 47,180 1,584,570
Interest paid (118,801 ) (159,800 )
Interest element of hire purchase payments
paid

(25,259

)

(30,530

)
Tax paid (6,355 ) (116,035 )
Net cash from operating activities (103,235 ) 1,278,205

Cash flows from investing activities
Purchase of tangible fixed assets (324,721 ) (693,776 )
Sale of tangible fixed assets 625 -
Interest received 6,354 2,034
Net cash from investing activities (317,742 ) (691,742 )

Cash flows from financing activities
Loans advanced / (repaid) 147,216 (377,356 )
Capital repayments in year (156,531 ) (174,588 )
Amount introduced by directors - 8
Net cash from financing activities (9,315 ) (551,936 )

(Decrease)/increase in cash and cash equivalents (430,292 ) 34,527
Cash and cash equivalents at beginning of
year

2

38,874

4,347

Cash and cash equivalents at end of year 2 (391,418 ) 38,874

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Cash Flow Statement
for the Year Ended 31 March 2025

1. RECONCILIATION OF (LOSS)/PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025 2024
£    £   
(Loss)/profit before taxation (236,327 ) 1,267,129
Depreciation charges 306,079 277,321
Loss on disposal of fixed assets 6,037 -
Finance costs 144,060 190,330
Finance income (6,354 ) (2,034 )
213,495 1,732,746
(Increase)/decrease in stocks (21,157 ) 218,621
Decrease/(increase) in trade and other debtors 146,457 (700,970 )
(Decrease)/increase in trade and other creditors (291,615 ) 334,173
Cash generated from operations 47,180 1,584,570

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2025
31.3.25 1.4.24
£    £   
Cash and cash equivalents - 38,874
Bank overdrafts (391,418 ) -
(391,418 ) 38,874
Year ended 31 March 2024
31.3.24 1.4.23
£    £   
Cash and cash equivalents 38,874 4,347


Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Cash Flow Statement
for the Year Ended 31 March 2025

3. ANALYSIS OF CHANGES IN NET DEBT

At 1.4.24 Cash flow At 31.3.25
£    £    £   
Net cash
Cash at bank 38,874 (38,874 ) -
Bank overdrafts - (391,418 ) (391,418 )
38,874 (430,292 ) (391,418 )
Debt
Finance leases (474,806 ) 156,531 (318,275 )
Debts falling due within 1 year (1,532,600 ) (40,736 ) (1,573,336 )
(2,007,406 ) 115,795 (1,891,611 )
Total (1,968,532 ) (314,497 ) (2,283,029 )

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Camstar Ingredients Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
The effects of the global economic situation have been carefully considered when preparing these financial statements. These financial statements continue to be prepared on a going concern basis as the directors are confident that the company is in a strong financial position to continue to trade going forward.The company has the ongoing financial support of its immediate parent company Camstar Herbs Limited if required.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Leasehold improvements - 10 years straight line
Plant and machinery - 10% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, and loans from banks or other related parties.

Debt instruments, like loans and other accounts receivable and payable, are initially measured at present value of the future payments and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration, expected to be paid or received. However if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an outright short-term loan not at market rate, the financial asset or liability is measured, initially and subsequently, at the present value of the future payment discounted at a market rate of interest for a similar debt instrument.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate, which is an approximation of the amount that the company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Impairment
At each reporting date tangible fixed assets are assessed to determine whether there is an indication that the carrying amount of an asset may be more than its recoverable amount and that the asset should be impaired. If there is an indication of possible impairment, the recoverable amount of an asset, which is the higher of its value in use and its net realisable value, is estimated and compared with its carrying amount. If the recoverable amount is lower, the carrying amount of the asset is written down to its estimated recoverable amount and an impairment loss is recognised in profit and loss.

3. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 3,561,285 2,867,285
Social security costs - 13,924
Other pension costs 40,082 36,883
3,601,367 2,918,092

The average number of employees during the year was as follows:
2025 2024

Directors 3 4
Other staff 77 64
80 68

2025 2024
£    £   
Directors' remuneration 225,844 235,837

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

3. EMPLOYEES AND DIRECTORS - continued

Information regarding the highest paid director is as follows:
2025 2024
£    £   
Emoluments etc 125,459 110,000

4. OPERATING (LOSS)/PROFIT

The operating loss (2024 - operating profit) is stated after charging:

2025 2024
£    £   
Repairs & renewals 233,205 301,360
Other operating leases 222,108 192,774
Depreciation - owned assets 230,704 176,982
Depreciation - assets on hire purchase contracts 75,375 100,338
Loss on disposal of fixed assets 6,037 -
Auditors' remuneration 5,000 5,000
Foreign exchange differences 6,386 301

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank & group finance interest 117,331 150,987
Bank charges 1,470 8,813
Hire purchase interest 25,259 30,530
144,060 190,330

6. TAXATION

Analysis of the tax charge
The tax charge on the loss for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax - 43,251
Adjustment re: previous years (19,172 ) (51,188 )
Total current tax (19,172 ) (7,937 )

Deferred tax 24,002 93,204
Tax on (loss)/profit 4,830 85,267

UK corporation tax was charged at 25%) in 2024.

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

6. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
(Loss)/profit before tax (236,327 ) 1,267,129
(Loss)/profit multiplied by the standard rate of corporation tax in the UK
of 25% (2024 - 25%)

(59,082

)

316,782

Effects of:
Expenses not deductible for tax purposes 483 9,831
Capital allowances in excess of depreciation (13,736 ) -
Utilisation of tax losses - (175,460 )
Adjustments to tax charge in respect of previous periods (19,172 ) (65,886 )
Group relieved losses 72,335 -

Deferred tax adjustment 24,002 -
Total tax charge 4,830 85,267

7. TANGIBLE FIXED ASSETS
Fixtures
Leasehold Plant and and Computer
improvements machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2024 512,399 3,136,193 26,837 59,509 3,734,938
Additions 8,214 266,084 4,997 45,426 324,721
Disposals - (8,350 ) - - (8,350 )
At 31 March 2025 520,613 3,393,927 31,834 104,935 4,051,309
DEPRECIATION
At 1 April 2024 139,057 873,648 19,387 30,159 1,062,251
Charge for year 51,122 237,747 2,815 14,395 306,079
Eliminated on disposal - (1,688 ) - - (1,688 )
At 31 March 2025 190,179 1,109,707 22,202 44,554 1,366,642
NET BOOK VALUE
At 31 March 2025 330,434 2,284,220 9,632 60,381 2,684,667
At 31 March 2024 373,342 2,262,545 7,450 29,350 2,672,687

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and
machinery
£   
COST
At 1 April 2024 930,642
Transfer to ownership (364,609 )
At 31 March 2025 566,033
DEPRECIATION
At 1 April 2024 176,895
Charge for year 75,375
Transfer to ownership (136,626 )
At 31 March 2025 115,644
NET BOOK VALUE
At 31 March 2025 450,389
At 31 March 2024 753,747

8. STOCKS
2025 2024
£    £   
Stocks 1,959,404 1,938,247

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 2,141,047 2,308,098
Other debtors 96,397 96,284
Corporation tax 149,499 123,972
Prepayments 243,495 223,014
2,630,438 2,751,368

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 12) 391,418 -
Other loans (see note 12) 1,573,336 1,532,600
Hire purchase contracts (see note 13) 117,583 156,517
Trade creditors 1,597,803 1,922,085
Amounts owed to group undertakings 291,772 185,292
Social security and other taxes 58,779 49,230
Other creditors 7,442 7,702
Accruals 92,984 69,606
4,131,117 3,923,032

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

11. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Hire purchase contracts (see note 13) 200,692 318,289

12. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts 391,418 -
Other loans 1,573,336 1,532,600
1,964,754 1,532,600

13. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2025 2024
£    £   
Net obligations repayable:
Within one year 117,583 156,517
Between one and five years 200,692 318,289
318,275 474,806

Non-cancellable
operating leases
2025 2024
£    £   
Within one year 47,766 16,745
Between one and five years 82,525 34,643
130,291 51,388

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

14. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£    £   
Other loans 1,573,336 1,532,600
Hire purchase contracts 318,275 474,806
1,891,611 2,007,406

Hire purchase liabilities are secured over the assets financed.

The bank hold a fixed and floating charge over all assets of the company to act as security for the invoice finance facility held by the company and also as security in relation to borrowing within the parent company, Camstar Herbs Limited.

15. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax
Accelerated capital allowances 568,812 544,810

Deferred
tax
£   
Balance at 1 April 2024 544,810
Provided during year 24,002
Balance at 31 March 2025 568,812

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
990 Ordinary £1 990 990

17. RESERVES
Capital
Retained Share redemption
earnings premium reserve Totals
£    £    £    £   

At 1 April 2024 2,609,810 4,165 80 2,614,055
Deficit for the year (241,157 ) (241,157 )
At 31 March 2025 2,368,653 4,165 80 2,372,898

Camstar Ingredients Limited (Registered number: 07849130)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

18. CONTINGENT LIABILITIES

Camstar Ingredients Limited guarantees the bank finance of its parent company Camstar Herbs Limited. The outstanding value of this loan in Camstar Herbs Limited at 31 March 2025 is £15,332,135 (2024: £13,306,625)

19. CAPITAL COMMITMENTS
2025 2024
£    £   
Contracted but not provided for in the
financial statements 221,866 32,365

20. RELATED PARTY DISCLOSURES

Entities with control, joint control or significant influence over the entity
2025 2024
£    £   
Sales 270,553 133,522
Purchases 1,730,459 1,644,408
Amount due to related party 291,772 185,292

Entities that provide key management personnel services to the entity
2025 2024
£    £   
Purchases 530 22,214
Amount due to related party - 8,454

21. ULTIMATE PARENT COMPANY

The ultimate parent company is Starke Industries Limited.
Registered Office : Chestnuts Farm, Langton Green, Eye, Suffolk, IP23 7HL